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Abstract
Introduction: Hemophagocytic lymphohistiocytosis is an immune-mediated syndrome that
typically has a rapidly progressive course that can result in pancytopenia, coagulopathy, multisystem organ failure and death.
Case presentation: A 57-year-old Caucasian woman was referred in fulminant hemophagocytic
lymphohistiocytosis, with fever, pancytopenia, splenomegaly, mental status changes and respiratory
failure. She was found to have stage IV classical Hodgkin lymphoma, in addition to Epstein-Barr virus
and cytomegalovirus viremia. Her presentation was preceded by a 3-year prodrome consisting of
cytopenia and fever that were partially controlled by steroids and azathioprine.
Conclusion: Fulminant hemophagocytic lymphohistiocytosis may follow a prodromal phase that
possesses features suggestive of a chronic form of hemophagocytic lymphohistiocytosis, but which
may also resemble immune cytopenias of other causes. A diagnosis of hemophagocytic
lymphohistiocytosis should be considered in the setting of chronic pancytopenia.

Introduction
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by fever, hepato-splenomegaly, lymphadenopathy,
pancytopenia,
rash,
and
hemophagocytosis by non-malignant macrophages [1,2].
Laboratory findings characteristic of this disease include
hypertriglyceridemia, hyperferritinemia, hypofibrinogenemia and liver function test abnormalities. The symptoms
of HLH are typically rapidly progressive, often resulting in
death from hemorrhage, multi-system organ failure, or
infection. Survival from HLH requires prompt recognition

of the syndrome, correction of its underlying cause, and
HLH-specific therapies such as etoposide [3].
HLH occurs in both inherited and acquired forms. Inherited forms have been attributed to defects in perforin
function and other intracellular pathways required for the
release of cytolytic granules by NK cells and cytotoxic Tlymphocytes [2]. In its acquired forms, HLH has been
associated with infections, such as Epstein-Barr virus
(EBV) and cytomegalovirus (CMV), inflammatory diseases, such as juvenile rheumatoid arthritis, and maligPage 1 of 7
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nancies, such as T-cell non-Hodgkin lymphoma and
Hodgkin lymphoma (HL) [2,4]. In HLH, an apparent loss
of restraint of the function of normal histiocytic cells is
correlated with the elaboration of high levels of interferon-γ by activated CD8+ T-cells and TNF-α and IL-6 by
activated macrophages [5].
Acquired forms of the disease typically follow a rapid
course. In a series of six cases associated with Epstein-Barr
infection, all of the patients died within 3 months of the
initial onset of symptoms [6]. In most cases associated
with HL, the first symptoms suggestive of HLH preceded
death or definitive therapy by only 1 to 2 months [7-11].

Case presentation
A 57-year-old Caucasian woman was admitted to a hospital in Philadelphia, PA, USA in October, 2006 for persistent fever and pancytopenia following debridement of a
buttock abscess.
Three years before her admission, she had rectal bleeding
and was found to have a platelet count of 65 × 109/liter

(laboratory reference values are given in Table 1). Upper
gastrointestinal (GI) workup revealed gastric ulcers with
an associated Helicobacter pylori infection. She received
appropriate therapy, but developed a rash and a decline in
her platelet count to 30 × 109/liter and her hemoglobin
(Hb) concentration to 80 g/liter. Bone marrow examination showed a hypercellular marrow with a myeloid left
shift. Computed tomography (CT) scan revealed
splenomegaly without focal lesions but no lymphadenopathy. She was treated with prednisone (1 mg/kg) for a presumed autoimmune anemia with thrombocytopenia
(Evans syndrome). Her anemia corrected, but her platelet
count rose to only 59 × 109/liter. She continued to have
cytopenias with febrile episodes. She received additional
courses of steroids and was maintained on azathioprine
(3.5 mg/kg/day). At one point, she had a white blood cell
count (WBC) nadir < 0.5 × 109/liter and was given filgrastim. Three months before her admission, she felt well and
was employed full-time. Her blood counts were: WBC 1.8
× 109/liter with an absolute neutrophil count of 1.386 ×
109cells/liter, Hb 108 g/liter, mean cell volume (MCV)
85.8 fL, platelet count 112 × 109/liter.

Table 1: Admission laboratory studies

Test
Sodium
Potassium
Chloride
Bicarbonate
BUN
Creatinine
Bilirubin, total
Bilirubin, direct
AST
ALT
Protein, total
Albumin
Triglycerides
LDH
Troponin
Iron
Iron binding capacity
Iron saturation
Ferritin
Haptoglobin
White blood cell count
Hemoglobin
Hematocrit
MCV
Platelets
PT
INR
PTT
Fibrinogen
D-dimer
Direct antiglobulin test

Change
H
L
L

H
H
H
H
L
L
H
H

L
H
L
L
L
L
L
H
H
H
L
H

Value

Reference values

126 mmol/liter
4.3 mmol/liter
94 mmol/liter
21 mmol/liter
7.5 mmol/liter
62 μmol/liter
46 μmol/liter
17 μmol/liter
78 U/liter
53 U/liter
39 g/liter
29 g/liter
4.2 mmol/liter
1068 U/liter
0.05 μg/liter
8.2 μg/dl
32.8 μg/dl
25%
20,392 μg/liter
<0.6 μmol/liter
2.7 × 109/liter
73 g/liter
0.21%
86 fl
15 × 109/liter
22.5 s
1.93
51 s
<0.6 g/liter
3.43 mg/liter
negative

135–146 mmol/liter
3.5–5.0 mmol/liter
98–109 mmol/liter
24–32 mmol/liter
2.5–7.5 mmol/liter
62–124 μmol/liter
3.4–21 μmol/liter
0.0–7 μmol/liter
7–35 U/liter
1–30 U/liter
60–85 g/liter
32–49 g/liter
<2.3 mmol/liter
100–200 U/liter
0.05–0.50 μg/liter
7.2–27.8 μg/dl
44.8–71.6 μg/dl
20–55%
20–150 μg/liter
2–16 μmol/liter
4–11 × 109/liter
125–150 g/liter
0.36–0.46
80–99 fl
140–400 × 109/liter
11.6–14.8 s
0.85–1.15
225–33 s
2.0–4.4 g/liter
<0.53 mg/liter

H, high value; L, low value; BUN, blood urea nitrogen; INR, international normalized ratio; PT, prothrombin time; PTT partial thromboplastin time;
Reference values are institutional standards converted to SI units.
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Eleven days before her referral, she was admitted to an
outside hospital with temperature of 38.6°C (101.5°F)
and a right buttock abscess. Her WBC was 0.5 × 109/liter,
Hb 75 g/liter, platelets 47 × 109/liter. The buttock lesion
was debrided. Bone marrow biopsy showed a hypercellular marrow with erythroid and megakaryocytic hyperplasia and clusters of atypical megakaryocytes. Her
medications included decadron 20 mg q 12 hours, filgrastim, darbepoietin, albumin, imipenem, diflucan, acyclovir, protonix, folate, and vitamin B12.

On the third hospital day, she had increased retroperitoneal bleeding, as indicated by expansion of her flank
ecchymosis and an increased red blood cell (RBC) transfusion requirement. She developed respiratory fatigue and
required mechanical ventilation. Bronchoscopic examination was unremarkable, but lavage cultures were positive
for Stenotrophomonas maltophilia and CMV. Ganciclovir
was initiated. She was extubated the following day, but
required bilevel positive airway pressure (BiPAP) and continued to have fever and a clouded sensorium.

Admission studies
Examination was notable for temperature 37.7°C
(100.0°F), blood pressure 126/68, respiratory rate 28,
pulse 122, oxygen saturation 92% on room air. She had
pallor, mild jaundice, a 2/6 systolic flow murmur,
splenomegaly, a 3 × 3 cm right buttock eschar, ecchymoses on her arms and left flank, and 3+ bilateral lower
extremity edema. She had no lymphadenopathy,
hepatomegaly, or musculoskeletal findings. Her mental
status exam was significant for a flat affect and orientation
to self, but not to the current year, the hospital name, or
her date of birth.

A bone marrow aspirate revealed a hypercellular bone
marrow containing maturing trilineage hematopoiesis
with prominent megakaryopoiesis and hyperplastic dyserythropoiesis (Figure 1A). The erythroid series showed
pronounced megaloblastoid change and abundant atypical erythroid precursors, including multinucleated normoblasts and many normoblasts with bizarre nuclear
configurations (Figure 1A). Occasional large foamy macrophages containing other hematopoietic elements were
noted. Rare very large atypical multinucleated cells with
basophilic cytoplasm and separate oval nuclei with prominent nucleoli were also identified (Figure 1B).

Laboratory studies (Table 1) were remarkable for pancytopenia and a coagulopathy. She had elevations in her ferritin, triglycerides, bilirubin, and liver function tests. Her
haptoglobin was low, but her direct anti-globulin test was
negative. Her peripheral blood smear demonstrated no
spherocytic or microangiopathic changes. An antinuclear
antibody (ANA) screen was also negative.

The bone marrow core biopsy revealed a hypercellular
marrow with background maturing trilineage hematopoiesis and a conspicuous increase in large histiocytes/macrophages, many of which contained hemosiderin and/or
other hematopoietic elements, consistent with hemophagocytosis. In addition, tumor nodules were present,
composed of large, irregular mononuclear cells with scattered, bizarre tumor giant cells containing hyperchromatic nuclei with coarse chromatin and prominent
macronucleoli (Figures 1C and 1D). Occasional binucleated Reed-Sternberg (RS) cells were noted (Figure 1E).
These tumor nodules occupied approximately 10% to
20% of the total marrow cross-sectional area within the
core biopsy and were accompanied by a reticulin fibrosis.
The tumor giant cells were strongly positive for CD30
(Figure 1F) and Ki67, but negative for other B-cell and Tcell markers, myeloid markers, CMV antigens and EBV
latent membrane protein (LMP). Significant histiocytosis
was also noted with phagocytosis of erythroid and myeloid cells (Figure 1G). CD68 staining revealed innumerable histiocytes/macrophages throughout the bone
marrow interstitium, many of which contained numerous
intact hematopoietic cells (Figure 1H). On the basis of
these studies, she received a diagnosis of Stage IV HL with
concurrent HLH.

Chest CT demonstrated bibasilar patchy pulmonary consolidation, small pleural effusions, and small calcified
mediastinal lymph nodes. Abdominal CT scan showed an
enlarged spleen with 10 low-density, indeterminate
lesions, similar lesions in the liver, bilateral renal infarcts,
and a left psoas hemorrhage. Head CT and echocardiography were unremarkable.
Hospital course
Decadron, antibiotics, and growth factors were continued.
A diagnosis of hemophagocytic syndrome was considered, and intravenous cyclosporine was started. Despite
aggressive transfusion support, minimal changes were
noted in her pancytopenia and coagulopathy. Blood cultures were negative for bacterial, fungal, and mycobacterial pathogens. EBV serologies were notable for IgG EBV
capsid protein and IgG EBNA antibodies, but negative for
IgM EBV capsid antibodies. EBV DNA copy number in the
blood was 27,800/ml, and the CMV DNA copy number
was 16,500/ml. Tests for human herpesvirus 6 (HHV-6),
Hepatitis C, Hepatitis B surface antigen, and human
immunodeficiency virus (HIV) were negative.

She received a single cycle of dose-reduced adriamycin,
bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy for treatment of her HL. Two days later, she had a
seizure of 2 to 3 minutes duration that involved her upper
extremities and facial muscles. Her bilirubin rose to 316
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Figure
Bone
marrow
1
Bone marrow. (A) Aspirate smears show many dysplastic erythroid precursors with bizarre nuclear configurations (arrows)
as well as (B) rare tumor giant cells (Wright Giemsa, original magnification ×1000). (C) Ill-defined tumor nodules efface the
bone marrow architecture within the core biopsy (hematoxylin and eosin, ×100). (D) The tumor nodules contain many irregular mononuclear cells as well as scattered bizarre multinucleated tumor giant cells with hyperchromatic nuclei with coarse
chromatin and macronucleoli (hematoxylin and eosin, ×400). (E) Occasional binucleated Reed-Sternberg like tumor cells are
present (hematoxylin and eosin, ×1000). Immunohistochemical studies performed on the bone marrow core biopsy are consistent with classical Hodgkin lymphoma. (F) The tumor cells are strongly positive for CD30 expression with membranous and
Golgi positivity (×400). (G) Within the bone marrow core biopsy, there is a conspicuous background histiocytosis with prominent hemophagocytosis (hematoxylin and eosin, ×400). Arrows indicate phagocytosed erythroid precursors (e) as well as an
ingested band form (b). (H) An immunohistochemical stain for CD68 highlights abundant background histiocytes, many of
which contain hematopoietic elements (×400).
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μmol/liter (18.5 mg/dl), ferritin to 34,820 μg/liter,
alanine aminotransferase (ALT) to 265 U/liter, and aspartate aminotransferase (AST) to 388 U/liter. Following a
discussion with her health care proxy, comfort measures
were instituted and she died the following day.
Post-mortem pathologic studies
Gross examination revealed severe jaundice, petechial
hemorrhages of the skin and gastric mucosa, mediastinal
lymphadenopathy, and a hematoma over the left psoas
muscle. Diffuse alveolar damage was noted in the lungs.
Classical HL was observed in the spleen, liver, bone marrow, left kidney, and paratracheal lymph nodes (Figures
2A and 2B). The tumor infiltrates contained RS cells (Figure 2C), which were positive for CD30 (Figure 2D) but
negative for other B-cell and T-cell markers and EBV LMP.
Taken together, the bone marrow and autopsy findings
confirmed a diagnosis of stage IV HL and HLH.

Discussion
In acquired cases of HLH, the clinical course is rapidly
progressive with multi-system organ failure often occurring within weeks of the initial diagnosis of the syndrome.
In our patient, fulminant HLH was present for approximately 3 weeks before her death. The standard definition
of HLH requires that at least 5 of 8 clinical criteria be met:
fever, splenomegaly, peripheral cytopenias of 2 or 3 lineages, hypertriglyceridemia, elevated ferritin (>500 μg/
liter), elevated soluble CD25 (sCD25), absent NK-cell
activity, and histological evidence of HLH in bone marrow, lymph nodes, or spleen. Our patient had six of these:
fever, splenomegaly, peripheral cytopenias of three lineages, hypertriglyceridemia, elevated ferritin, and histological evidence of HLH. Typical of HLH, she also had a
coagulopathy, liver function test abnormalities, an elevated LDH, and CNS dysfunction.
It is possible that our patient had a chronic form of HLH.
For 3 years before her admission, three of the diagnostic
criteria for HLH were present: fever, cytopenias, splenomegaly. Additional laboratory studies to support the diagnosis were not obtained (triglycerides, ferritin, sCD25,
and NK-cell activity). A bone marrow biopsy did not show
hemophagocytic cells, but initial bone marrow biopsies
are insensitive tests for the diagnosis of HLH [2]. In addition, there are few competing explanations for her cytopenias. In the absence of a clinically apparent malignancy
and excluding HLH, the differential diagnosis for pancytopenia includes premalignant, inflammatory, infectious,
genetic, and toxic causes (Table 2). Most of these could be
ruled out on the basis of the history and laboratory studies. Furthermore, bone marrow did not show any premalignant, infiltrative or infectious processes, no toxins were
involved, and an infection with parvovirus would have
been self-limited.

http://www.jmedicalcasereports.com/content/2/1/367

Table 2: Non-malignant syndromes that can cause pancytopenia
without HLH

Infectious
Parvovirus B-19
Visceral leishmaniasis
Bone marrow failure
Aplastic anemia
Myelodysplastic syndrome
Myelofibrosis
Vitamin B12 deficiency
Folate deficiency
Paroxysmal nocturnal hemoglobinuria
Sarcoidosis
Fanconi anemia
Gaucher disease
Niemann-Pick disease
Inflammatory/Immune
Transfusion-associated graft-versus-host disease
Evan's syndrome
Autoimmune lymphoproliferative syndrome
Aplastic anemia
Systemic lupus erythematosus
Toxic
Alcohol
Arsenic
Cyanide
Quinine
Methotrexate
Terfinabine
Tocainamide
Parvovirus and visceral leishmaniasis can also cause pancytopenia by
inducing HLH. A diversity of infections can cause pancytopenia when
associated with HLH. These are reviewed in Ref. 4 and at http://
www.cdc.gov/ncidod/eid/vol6no6/fisman_refs.htm.

If our patient did have chronic HLH, what was the most
likely cause? At the time of her death, she had three conditions associated with HLH: active EBV infection, active
CMV infection, and HL. Her chronic HLH may have been
the result of any of these, but we consider HL to be the
most likely cause, since occult HL can exist for many years
[12]. In contrast, acute EBV and CMV infections are associated with fever, pharyngitis, lymphadenopathy, and
fatigue and would likely have been self-limited. EBV antigens are commonly expressed by RS cells in patients with
HL and HLH [13]. In our patient, the RS cells were negative for EBV LMP, indicating that her HL and EBV reactivation were independent disease processes. Treatment with
azathioprine and steroids may have facilitated reactivation of EBV and CMV late in her disease course while partially treating her HLH and HL.

Conclusion
We have described a case of acquired HLH that presented
in a fulminant form following a 3-year prodrome that was
consistent with a mild, chronic form of HLH. Chronic
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Figureat2 autopsy
Spleen
Spleen at autopsy. (A) Multiple tumor nodules efface the normal splenic architecture (hematoxylin and eosin, ×100). (B) The
tumor nodules consist of clusters of numerous bizarre multinucleated tumor giant cells with irregular nuclei and coarse chromatin (hematoxylin and eosin, ×400). (C) Occasional classic Reed-Sternberg like tumor cells with macronucleoli are also
present (hematoxylin and eosin, ×1000). (D) An immunostain for CD30 highlights the majority of the tumor giant cells (×100).
HLH should be considered in the differential diagnosis of
fever, splenomegaly and pancytopenia.
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RBC: red blood cell; RS: Reed-Sternberg cell; sCD25: soluble CD25; WBC: white blood cell count
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